ANIP Insider Transactions
433 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ANIP insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Lalwani Nikhil | PRESIDENT & CEO | 2026-08-25 | Sale | 5,400 | $74.30 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-08-13 | Sale | 500 | $75.48 |
| Gutwerg Ori | SVP, GENERICS | 2026-08-10 | Sale | 3,162 | $77 |
| CAREY STEPHEN P. | SVP & CFO | 2026-07-29 | Sale | 2,850 | $81.36 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-07-13 | Sale | 500 | $81.84 |
| CAREY STEPHEN P. | SVP & CFO | 2026-07-02 | Sale | 3,313 | $86 |
| CAREY STEPHEN P. | SVP & CFO | 2026-06-29 | Sale | 2,850.0 | $84.12 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-06-12 | Sale | 500.0 | $82.03 |
| HAUGHEY THOMAS | Director | 2026-06-08 | Sale | 2,000.0 | $80.88 |
| CAREY STEPHEN P. | SVP & CFO | 2026-06-05 | Sale | 3,312.0 | $80.0 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-05-13 | Sale | 500.0 | $78.16 |
| Walsh Patrick D | Director | 2026-05-13 | Sale | 10,000.0 | $80.63 |
| Gutwerg Ori | SVP, GENERICS | 2026-05-12 | Sale | 2,772.0 | $79.5 |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2026-05-12 | Sale | 459.0 | $79.21 |
| Lalwani Nikhil | PRESIDENT & CEO | 2026-05-11 | Sale | 55,000.0 | $77.57 |
| Walsh Patrick D | Director | 2026-05-11 | Sale | 3,973.0 | $80.75 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-04-13 | Sale | 500.0 | $77.95 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-03-13 | Sale | 500.0 | $72.62 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-13 | Sale | 3,162.0 | $71.64 |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2026-03-11 | Sale | 4,772.0 | $74.91 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-03-09 | Sale | 5,087.0 | $74.13 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-09 | Sale | 3,602.0 | $74.18 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-03-06 | Sale | 1,485.0 | $75.0 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-06 | Sale | 2,121.0 | $74.22 |
| CAREY STEPHEN P. | SVP & CFO | 2026-03-05 | Sale | 4,000.0 | $75.56 |
| CAREY STEPHEN P. | SVP & CFO | 2026-03-05 | Sale | 3,312.0 | $75.42 |
| Gutwerg Ori | SVP, GENERICS | 2026-03-03 | Sale | 2,060.0 | $76.5 |
| Walsh Patrick D | Director | 2026-03-03 | Sale | 6,000.0 | $74.23 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-02 | Sale | 417.0 | $74.0 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-02-20 | Sale | 1,730.0 | $77.99 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-02-20 | Sale | 5,323.0 | $78.02 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-02-19 | Sale | 2,084.0 | $77.53 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-02-13 | Sale | 500.0 | $76.8 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-02-12 | Sale | 7,032.0 | $76.55 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-01-13 | Sale | 500.0 | $84.33 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-12-18 | Sale | 1,622.0 | $82.4 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-12-12 | Sale | 400.0 | $82.32 |
| TANNENBAUM RENEE P | Director | 2025-12-05 | Sale | 1,800.0 | $81.15 |
| Walsh Patrick D | Director | 2025-11-13 | Sale | 8,643.0 | $86.88 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-11-13 | Sale | 400.0 | $87.27 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2025-11-13 | Sale | 94.0 | $88.0 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2025-11-12 | Sale | 14,642.0 | $89.07 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-10-13 | Sale | 400.0 | $90.09 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-09-19 | Sale | 1,000.0 | $98.04 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-09-12 | Sale | 400.0 | $98.42 |
| Pera Antonio R | Director | 2025-09-03 | Sale | 7,292.0 | $94.94 |
| Leonard Matthew J | Director | 2025-08-25 | Sale | 2,528.0 | $90.62 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-08-22 | Sale | 1,763.0 | $91.1 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-21 | Sale | 52,988.0 | $90.44 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-20 | Sale | 47,012.0 | $90.27 |
| Pera Antonio R | Director | 2025-08-20 | Sale | 5,421.0 | $89.73 |
| Thoma Jeanne | Director | 2025-08-18 | Sale | 14,675.0 | $88.87 |
| Thoma Jeanne | Director | 2025-08-18 | Sale | 6,865.0 | $89.76 |
| Leonard Matthew J | Director | 2025-08-18 | Sale | 6,937.0 | $88.17 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2025-08-15 | Sale | 20,000.0 | $86.97 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-15 | Sale | 52,990.0 | $87.15 |
| Walsh Patrick D | Director | 2025-08-15 | Sale | 9,000.0 | $89.05 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-14 | Sale | 47,010.0 | $89.48 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-08-13 | Sale | 400.0 | $88.87 |
| Gutwerg Ori | SVP, GENERICS | 2025-08-12 | Sale | 5,873.0 | $86.53 |
| Lalwani Nikhil | PRESIDENT & CEO | 2025-08-12 | Sale | 56,960.0 | $85.93 |
| CAREY STEPHEN P. | SVP & CFO | 2025-08-12 | Sale | 50,000.0 | $86.07 |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2025-08-12 | Sale | 4,975.0 | $85.71 |
| HAUGHEY THOMAS | Director | 2025-08-12 | Sale | 19,341.0 | $85.93 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-07-14 | Sale | 400.0 | $64.88 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-06-13 | Sale | 400.0 | $61.37 |
| Gutwerg Ori | SVP, GENERICS | 2025-05-15 | Sale | 881.0 | $60.07 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2025-05-14 | Sale | 4,000.0 | $60.45 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-05-13 | Sale | 400.0 | $62.2 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-05-09 | Sale | 700.0 | $76.83 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-04-14 | Sale | 400.0 | $68.96 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-03-19 | Sale | 1,866.0 | $65.0 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-03-13 | Sale | 400.0 | $63.33 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-03-07 | Sale | 1,000.0 | $60.86 |
| Gutwerg Ori | SVP, GENERICS | 2025-03-05 | Sale | 5,084.0 | $60.0 |
| Gutwerg Ori | SVP, GENERICS | 2025-03-05 | Sale | 300.0 | $60.03 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-02-21 | Sale | 1,000.0 | $60.2 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-02-13 | Sale | 400.0 | $59.54 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-01-13 | Sale | 400.0 | $53.92 |
| CAREY STEPHEN P. | SVP & CFO | 2024-12-17 | Sale | 7,500.0 | $55.79 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-12-13 | Sale | 250.0 | $56.24 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2024-12-11 | Sale | 1,000.0 | $60.0 |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-11-26 | Sale | 3,481.0 | $58.3 |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-11-26 | Sale | 30,000.0 | $57.95 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-11-15 | Sale | 6,500.0 | $57.7 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-11-13 | Sale | 250.0 | $61.36 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-10-14 | Sale | 250.0 | $57.19 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-09-13 | Sale | 250.0 | $56.82 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-08-13 | Sale | 250.0 | $59.62 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-18 | Sale | 2,743.0 | $62.0 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-17 | Sale | 14,257.0 | $63.16 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-16 | Sale | 22,000.0 | $64.27 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-15 | Sale | 11,000.0 | $63.38 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-07-12 | Sale | 250.0 | $64.91 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-07-01 | Sale | 20,000.0 | $63.44 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-21 | Sale | 20,000.0 | $58.9 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-20 | Sale | 11,447.0 | $59.86 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-18 | Sale | 10,607.0 | $60.76 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-17 | Sale | 7,946.0 | $61.41 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-06-13 | Sale | 250.0 | $63.8 |